CLL cells display intrinsic high levels of ROS/oxidative stress and upregulated HMOX1 expression, compared to normal B cells and these characteristics could constitute therapeutic targets [23, 24]. Here, HMOX1 is linked to B-cell chronic lymphocytic leukemia.